Research in peripheral T-cell lymphoma (PTCL) is moving in exciting directions. Scientists are exploring the many different subtypes of PTCL to better understand how the disease works and why it behaves differently in each patient. New treatments, including advanced immunotherapies and targeted therapies, are being studied to improve outcomes and offer more personalized care for people living with this rare lymphoma.
In this video, Francine Foss, MD, the director of the T-cell lymphoma program at Yale School of Medicine, discusses advances in PTCL treatment.
DISCLAIMER: This video is for informational purposes only and should not be taken as medical advice. Each patient’s situation is unique and we strongly advise viewers to consult a qualified T-cell lymphoma specialist to discuss personalized treatment options.